Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Clinical trial NCT06872489 · AVAILABLE

Trial details

NCT number: NCT06872489
Sponsor: Second Life Therapeutics
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Neuroblastoma in Children Neuroblastoma, Recurrent, Refractory Advanced Cancer Advanced Malignant Neoplasm Prostate Cancer Patients With Bone Metastasis Lung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer - Non Small Cell Gastrointestinal Cancers Head and Neck Cancer Pancreatic Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.